Hydrophobic proteome analysis of triple negative and hormone-receptor- positive-her2-negative breast cancer by mass spectrometer

Clinical Proteomics

Volumn 6, Issue 3, 2010, Pages 93-103

  Lu, Ming ^a   Whelan, Stephen A ^a   He, Jianbo ^a   Saxton, Romaine E ^a   Faull, Kym F ^a   Whitelegge, Julian P ^a   Chang, Helena R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer biomarker; Hormone receptor positive Her2 negative breast cancer; Hydrophobic fractionation; Mass spectrometry; Triple negative breast cancer

Indexed keywords

CELL MEMBRANE PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEAT SHOCK PROTEIN; KERATIN; PROTEOME;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; UPREGULATION;

EID: 77956647455     PISSN: 15426416     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12014-010-9052-1     Document Type: Article

References (55)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
2. S Cleator W Heller RC Coombes 2007 Triple-negative breast cancer: therapeutic options Lancet Oncol 8 235 244 10.1016/S1470-2045(07)70074-8 17329194 (Pubitemid 46291713)
3. SP Kang M Martel LN Harris 2008 Triple negative breast cancer: current understanding of biology and treatment options Curr Opin Obstet Gynecol 20 40 66 10.1097/GCO.0b013e3282f40de9 18197004
4. CM Perou T Sørlie MB Eisen, et al. 2000 Molecular portraits of human breast tumours Nature 406 747 752 1:CAS:528:DC%2BD3cXmt1CnsLw%3D 10.1038/35021093 10963602
5. T Sorlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 1:CAS:528:DC%2BD3sXlsFGntLk%3D 10.1073/pnas.0932692100 12829800 (Pubitemid 36842560)
6. TO Nielsen FD Hsu K Jensen, et al. 2004 Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 5367 5374 1:CAS:528:DC%2BD2cXmvFSlt7k%3D 10.1158/1078-0432.CCR-04- 0220 15328174 (Pubitemid 39100473)
7. LN Harris F You SJ Schnitt, et al. 2007 Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer Clin Cancer Res 13 1198 1207 1:CAS:528:DC%2BD2sXhvF2hsbo%3D 10.1158/1078-0432. CCR-06-1304 17317830 (Pubitemid 46424061)
8. LA Carey CM Perou CA Livasy, et al. 2006 Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2492 2502 1:CAS:528:DC%2BD28XlsV2rtLw%3D 10.1001/jama.295.21.2492 16757721 (Pubitemid 43854964)
9. KR Bauer M Brown RD Cress, et al. 2007 Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a populationbased study from the California cancer Registry Cancer 109 1721 1728 10.1002/cncr.22618 17387718 (Pubitemid 46668532)
10. SJ Dawson E Provenzano C Caldas 2009 Triple negative breast cancers: clinical and prognostic implications Eur J Cancer 45 Suppl 1 27 40 10.1016/S0959-8049(09)70013-9 19775602
11. BJ Furr VC Jordan 1984 The pharmacology and clinical uses of tamoxifen Pharmacol Ther 25 127 205 1:CAS:528:DyaL2MXhs12nug%3D%3D 10.1016/0163-7258(84) 90043-3 6438654
12. R Dent M Trudeau KI Pritchard, et al. 2007 Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence Clin Cancer Res 13 4429 4434 10.1158/1078-0432.CCR-06-3045 17671126 (Pubitemid 47219710)
13. VC Jordan 2006 Tamoxifen (ICI46, 474) as a targeted therapy to treat and prevent breast cancer Br J Pharmacol 147 Suppl 1 S269 276 1:CAS:528: DC%2BD28XisVCnsA%3D%3D 10.1038/sj.bjp.0706399 16402113 (Pubitemid 43077285)
14. J He J Gornbein D Shen, et al. 2007 Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry Int J Oncol 30 145 154 1:CAS:528:DC%2BD2sXhtFyrtb8%3D 17143523
15. H Shau GS Chandler JP Whitelegge JA Gornbein KF Faull HR Chang 2003 Proteomic profiling of cancer biomarkers Brief Funct Genomic Proteomic 2 147 158 1:CAS:528:DC%2BD3sXmvFSlsrk%3D 10.1093/bfgp/2.2.147 15239937
16. J He D Shen DU Chung, et al. 2009 Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapy Int J Oncol 35 683 692 1:CAS:528:DC%2BD1MXht1Wju7jL 19724903
17. SA Whelan M Lu J He, et al. 2009 Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers J Proteome Res 8 4151 4160 1:CAS:528:DC%2BD1MXos1Ons7g%3D 10.1021/pr900322g 19522481
18. M Lu KF Faull JP Whitelegge RK Saxton D Shen HR Chang 2007 Mass spectrometry for cancer biomarker discovery Biomark Insights 2 347 360 19662217
19. M Lu JP Whitelegge SA Whelan, et al. 2010 Hydrophobic fractionation enhances novel protein detection by mass spectrometry in triple negative breast cancer J Proteomics Bioinform 3 1 10 10.4172/jpb.1000114 20596302
20. T Hirokawa S Boon-Chieng S Mitaku 1998 SOSUI: classification and secondary structure prediction system for membrane proteins Bioinformatics 14 378 379 1:CAS:528:DyaK1cXks12gt70%3D 10.1093/bioinformatics/14.4.378 9632836
21. AL Hopkins CR Groom 2002 The druggable genome Nat Rev Drug Discov 1 727 730 1:CAS:528:DC%2BD38XmslamtrY%3D 10.1038/nrd892 12209152
22. AE Speers CC Wu 2007 Proteomics of integral membrane proteins-theory and application Chem Rev 107 3687 3714 1:CAS:528:DC%2BD2sXos1egs7o%3D 10.1021/cr068286z 17683161 (Pubitemid 47322748)
23. JP Whitelegge F Halgand P Souda V Zabrouskov 2006 Top-down mass spectrometry of integral membrane proteins Expert Rev Proteomics 3 585 596 1:CAS:528:DC%2BD2sXhvFGqtro%3D 10.1586/14789450.3.6.585 17181473 (Pubitemid 46021197)
24. JP Whitelegge 2005 Mass spectrometry for high throughput quantitative proteomics in plant research: lessons from thylakoid membranes Plant Physiol Biochem 42 919 927 10.1016/j.plaphy.2004.11.005
25. JP Whitelegge CB Gunderson KF Faulk 1998 Electrospray-ionization mass spectrometry of intact intrinsic membrane proteins Protein Sci 7 1423 1430 1:CAS:528:DyaK1cXjvFGqs7c%3D 10.1002/pro.5560070619 9655347
26. JP Whitelegge J Katz K Pihakari, et al. 2004 Subtle modification of isotope ratio proteomics (SMIRP); a new strategy for expression proteomics Phytochemistry 65 1507 1515 1:CAS:528:DC%2BD2cXmtVCjsr0%3D 10.1016/j.phytochem. 2004.05.018 15276448 (Pubitemid 38969933)
27. JP Whitelegge J Le Coutre JC Lee, et al. 1999 Towards the bilayer proteome electrospray ionization mass spectrometry of large intact membrane proteins Proc Natl Acad Sci 96 10695 10698 1:CAS:528:DyaK1MXmtFKjsr8%3D 10.1073/pnas.96.19.10695 10485888 (Pubitemid 29442206)
28. JP Whitelegge 2005 Tandem mass spectrometry of integral membrane proteins for top-down proteomics Trends Anal Chem 24 576 582 1:CAS:528: DC%2BD2MXntVCgsb0%3D 10.1016/j.trac.2005.04.010 (Pubitemid 41021496)
29. R Craig RC Beavis 2003 A method for reducing the time required to match protein sequences with tandem mass spectra Rapid Commun Mass Spectrom 17 2310 2316 1:CAS:528:DC%2BD3sXotlGnur8%3D 10.1002/rcm.1198 14558131
30. AI Nesvizhskii A Keller E Kolker R Aebersold 2003 A statistical model for identifying proteins by tandem mass spectrometry Anal Chem 75 4646 4658 1:CAS:528:DC%2BD3sXltlynt70%3D 10.1021/ac0341261 14632076 (Pubitemid 37082259)
31. A Keller AI Nesvizhskii E Kolker R Aebersold 2002 Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search Anal Chem 74 5383 5392 1:CAS:528:DC%2BD38XmvVyktL4%3D 10.1021/ac025747h 12403597 (Pubitemid 35215372)
32. R Moll M Divo L Langbein 2008 The human keratins: biology and pathology Histochem Cell Biol 129 705 733 1:CAS:528:DC%2BD1cXlvFajt78%3D 10.1007/s00418-008-0435-6 18461349
33. SC Tseng MJ Jarvinen WG Nelson JW Huang J Woodcock-Mitchell TT Sun 1982 Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies Cell 30 361 372 1:CAS:528:DyaL38Xlsl2ht7g%3D 10.1016/0092-8674(82)90234-3 6183000
34. YJ Wu LM Parker NE Binder, et al. 1982 The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia Cell 31 693 703 1:CAS:528:DyaL3sXkvFSgug%3D%3D 10.1016/0092-8674(82)90324-5 6186388
35. C Didelot D Lanneau M Brunet, et al. 2007 Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins Curr Med Chem 14 2839 2847 1:CAS:528:DC%2BD1cXhtlSku7c%3D 10.2174/092986707782360079 18045130 (Pubitemid 350201651)
36. J Schweizer PE Bowden PA Coulombe, et al. 2006 New consensus nomenclature for mammalian keratins J Cell Biol 174 169 174 1:CAS:528:DC%2BD28XntFaqsb0%3D 10.1083/jcb.200603161 16831889 (Pubitemid 44079852)
37. L Ma J Xu PA Coulombe D Wirtz 1999 Keratin filament suspensions show unique micromechanical properties J Biol Chem 274 19145 19451 1:CAS:528:DyaK1MXksVWlt74%3D 10.1074/jbc.274.27.19145 10383419 (Pubitemid 29314113)
38. SE Cross YS Jin J Rao JK Gimzewski 2007 Nanomechanical analysis of cells from cancer patients Nat Nanotechnol 2 780 783 1:CAS:528:DC%2BD2sXhtlyktL7L 10.1038/nnano.2007.388 18654431 (Pubitemid 350223349)
39. SR Donnelly SE Moss 1997 Annexins in the secretory pathway Cell Mol Life Sci 53 533 538 1:CAS:528:DyaK2sXktlGntb4%3D 10.1007/s000180050068 9230932 (Pubitemid 27374495)
40. CE Creutz CJ Pazoles HB Pollard 1978 Identification and purification of an adrenal medullary protein (synexin) that causes calcium-dependent aggregation of isolated chromaffin granules J Biol Chem 253 2858 2866 1:CAS:528: DyaE1cXhvVCqsbs%3D 632306
41. H Kenis H van Genderen A Bennaghmouch, et al. 2004 Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry J Biol Chem 279 52623 52629 1:CAS:528:DC%2BD2cXhtVCkurrI 10.1074/jbc.M409009200 15381697 (Pubitemid 39656638)
42. V Gerke CE Creutz SE Moss 2005 Annexins: linking Ca2+ signalling to membrane dynamics Nat Rev Mol Cell Biol 6 449 461 1:CAS:528:DC%2BD2MXks1Gmtbo%3D 10.1038/nrm1661 15928709 (Pubitemid 40780557)
43. Y Liu Z Xiao M Li, et al. 2009 Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma J Pathol 106 570 579
44. S Liu MZ Sun JW Tang Z Wang C Sun FT Greenaway 2008 High-performance liquid chromatography/nanoelectrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarkers Rapid Commun Mass Spectrom 22 3172 3178 1:CAS:528:DC%2BD1cXhtleiu7%2FK 10.1002/rcm.3725 18798201
45. A De Maio 1999 Heat shock proteins: facts, thoughts, and dreams Shock 11 1 1 12 10.1097/00024382-199901000-00001 9921710
46. SK Calderwood DR Ciocca 2008 Heat shock proteins: stress proteins with Janus-like properties in cancer Int J Hyperthermia 24 31 39 1:CAS:528: DC%2BD1cXovFKnsw%3D%3D 10.1080/02656730701858305 18214767 (Pubitemid 351167617)
47. DB Solit N Rosen 2006 Hsp90: a novel target for cancer therapy Curr Top Med Chem 6 1205 1214 1:CAS:528:DC%2BD28Xpt1ejtLo%3D 10.2174/156802606777812068 16842157 (Pubitemid 44120915)
48. DR Ciocca SK Calderwood 2005 Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications Cell Stress Chaperones 10 86 103 1:CAS:528:DC%2BD2MXmsFymur4%3D 10.1379/CSC-99r.1 16038406 (Pubitemid 40942470)
49. M Jaattela 1999 Escaping Cell Death: Survival Proteins in Cancer Exp Cell Res 248 30 43 1:CAS:528:DyaK1MXitVWns7k%3D 10.1006/excr.1999.4455 10094811 (Pubitemid 29393927)
50. DD Mosser AW Caron L Bourget, et al. 2000 The chaperone function of hsp70 is required for protection against stress-induced apoptosis Mol Cell Biol 20 7146 7159 1:CAS:528:DC%2BD3cXms1CjtLg%3D 10.1128/MCB.20.19.7146-7159.2000 10982831
51. MHC Sequencing Consortium 1999 Complete sequence and gene map of a human major histocompatibility complex Nature 401 921 923 10.1038/44853 (Pubitemid 29518961)
52. Leong PP, Muhammad R, Ibrahim N, Cheong SK, Seow HF. HLA-A and breast cancer in West Peninsular Malaysia. Med Oncol 2010; in press.
53. X He DD Dong SM Yie, et al. 2010 HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro Ann Surg Oncol 17 1459 1469 10.1245/s10434-009-0891-9 20052552
54. D Sayed G Badr D Maximous NN Mikhail F Abu-Tarboush IM Alhazza 2010 HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients Tissue Antigens 75 40 47 1:CAS:528:DC%2BC3cXht1Khs70%3D 10.1111/j.1399-0039.2009.01393.x 20196818
55. EM de Kruijf JG van Nes A Sajet, et al. 2010 The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer Clin Cancer Res 16 1272 1280 10.1158/1078-0432.CCR-09-1844 20145162